Summary by Moomoo AI
Kunshengtai Medicine-B (Stock Code: 2511) will hold a board of directors meeting on Wednesday, August 28, 2024 to review and approve the company and its subsidiaries' mid-term performance up to June 30, 2024. The meeting will be chaired by Executive Director and CEO Dr. Liu Liping, and attended by other board members including Executive Director Ms. Yu Meng; non-executive directors Dr. Zhu Xun, Mr. Ma Lixiong, and Mr. Jiang Feng; as well as independent non-executive directors Mr. Tan Biaozheng, Dr. Li Jing, and Mr. Kong Dewei. The meeting will help shareholders to understand the company's financial status and business development.